JP2014518285A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014518285A5 JP2014518285A5 JP2014519451A JP2014519451A JP2014518285A5 JP 2014518285 A5 JP2014518285 A5 JP 2014518285A5 JP 2014519451 A JP2014519451 A JP 2014519451A JP 2014519451 A JP2014519451 A JP 2014519451A JP 2014518285 A5 JP2014518285 A5 JP 2014518285A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- solvent
- surfactant
- solution
- weigh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11290320A EP2545905A1 (en) | 2011-07-11 | 2011-07-11 | A new therapeutical composition containing apomorphine as active ingredient |
| EP11290320.8 | 2011-07-11 | ||
| PCT/EP2012/002916 WO2013007381A1 (en) | 2011-07-11 | 2012-07-11 | A new therapeutical composition containing apomorphine as active ingredient |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016238705A Division JP2017081947A (ja) | 2011-07-11 | 2016-12-08 | 活性成分としてアポモルヒネを含む、新たな治療的組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014518285A JP2014518285A (ja) | 2014-07-28 |
| JP2014518285A5 true JP2014518285A5 (enExample) | 2016-07-14 |
| JP6356064B2 JP6356064B2 (ja) | 2018-07-11 |
Family
ID=46514305
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014519451A Active JP6356064B2 (ja) | 2011-07-11 | 2012-07-11 | 活性成分としてアポモルヒネを含む、新たな治療的組成物。 |
| JP2016238705A Pending JP2017081947A (ja) | 2011-07-11 | 2016-12-08 | 活性成分としてアポモルヒネを含む、新たな治療的組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016238705A Pending JP2017081947A (ja) | 2011-07-11 | 2016-12-08 | 活性成分としてアポモルヒネを含む、新たな治療的組成物 |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US11026938B2 (enExample) |
| EP (2) | EP2545905A1 (enExample) |
| JP (2) | JP6356064B2 (enExample) |
| KR (1) | KR101990897B1 (enExample) |
| CN (2) | CN108434094A (enExample) |
| AU (1) | AU2012283381B2 (enExample) |
| BR (1) | BR112014000306B1 (enExample) |
| CA (1) | CA2841807C (enExample) |
| CL (1) | CL2014000050A1 (enExample) |
| CO (1) | CO6870038A2 (enExample) |
| CR (1) | CR20140005A (enExample) |
| CU (1) | CU24159B1 (enExample) |
| DO (1) | DOP2014000003A (enExample) |
| EA (1) | EA025870B1 (enExample) |
| EC (1) | ECSP14013200A (enExample) |
| GE (1) | GEP20196969B (enExample) |
| GT (1) | GT201400003A (enExample) |
| IL (1) | IL230308A (enExample) |
| IN (1) | IN2014DN00090A (enExample) |
| MA (1) | MA35411B1 (enExample) |
| MX (2) | MX389600B (enExample) |
| MY (1) | MY168212A (enExample) |
| NI (1) | NI201400003A (enExample) |
| PE (1) | PE20141539A1 (enExample) |
| PH (1) | PH12014500065A1 (enExample) |
| SG (1) | SG10201605491PA (enExample) |
| TN (1) | TN2014000001A1 (enExample) |
| UA (1) | UA113962C2 (enExample) |
| WO (1) | WO2013007381A1 (enExample) |
| ZA (1) | ZA201309711B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2545905A1 (en) * | 2011-07-11 | 2013-01-16 | Britannia Pharmaceuticals Limited | A new therapeutical composition containing apomorphine as active ingredient |
| NZ703341A (en) | 2012-06-05 | 2016-11-25 | Neuroderm Ltd | Compositions comprising apomorphine and organic acids and uses thereof |
| EP2918266A1 (en) | 2014-03-11 | 2015-09-16 | CDRD Berolina AB | Composition comprising a dopamine agonist and an L-DOPA derivative for treating Parkinson's disease |
| EP2979688A1 (en) * | 2014-08-01 | 2016-02-03 | Britannia Pharmaceuticals Limited | Composition containing Apomorphine and a Divalent Metal Cation |
| CN107548388A (zh) * | 2014-12-23 | 2018-01-05 | 纽罗德姆有限公司 | 阿朴吗啡的晶体形态及其用途 |
| CA2999675C (en) * | 2015-09-28 | 2023-10-17 | Ever Neuro Pharma Gmbh | Aqueous composition of apomorphine for subcutaneous administration |
| CN114007617A (zh) * | 2019-05-31 | 2022-02-01 | 葡瑞慕生物技术有限公司 | 用于经黏膜给药药物活性成分的单位剂型 |
| CN114980896A (zh) * | 2019-08-07 | 2022-08-30 | 阿克里普斯一有限公司 | (6AS)-6-甲基-5,6,6A,7-四氢-4H-二苯并[de,g]喹啉-10,11-二醇的药物组合物 |
| GB201912686D0 (en) * | 2019-09-04 | 2019-10-16 | Reown Pharma Inc | Pharmaceutical composition |
| JP7703231B2 (ja) | 2020-05-20 | 2025-07-07 | 株式会社 メドレックス | アポモルヒネ含有経皮吸収型製剤 |
| WO2022271537A1 (en) * | 2021-06-25 | 2022-12-29 | President And Fellows Of Harvard College | Compositions and methods relating to injectable microemulsions |
| AU2023291260A1 (en) | 2022-06-15 | 2025-01-02 | Ever Neuro Pharma Gmbh | Apomorphine prodrugs and uses thereof |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1662566A1 (ru) * | 1988-03-05 | 1991-07-15 | Всесоюзный Научно-Исследовательский Институт Биотехнологии | Способ стабилизации инъекционного раствора апоморфина |
| JP2822049B2 (ja) * | 1989-02-02 | 1998-11-05 | ゼリア新薬工業株式会社 | 水性製剤組成物 |
| DE69432789T2 (de) * | 1993-03-26 | 2003-12-04 | Franciscus Wilhelmus H.M. Merkus | Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin |
| US6121276A (en) * | 1994-04-22 | 2000-09-19 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| US5562917A (en) * | 1994-12-23 | 1996-10-08 | Pentech Pharmaceuticals, Inc. | Transdermal administration of apomorphine |
| US5945117A (en) | 1998-01-30 | 1999-08-31 | Pentech Pharmaceuticals, Inc. | Treatment of female sexual dysfunction |
| JP3723857B2 (ja) * | 1998-02-04 | 2005-12-07 | 日本ケミカルリサーチ株式会社 | ヒト成長ホルモン含有水性医薬組成物 |
| US6011043A (en) | 1998-06-19 | 2000-01-04 | Schering Corporation | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction |
| US6436950B1 (en) * | 1998-08-14 | 2002-08-20 | Nastech Pharmaceutical Company, Inc. | Nasal delivery of apomorphine |
| US5994363A (en) * | 1998-08-24 | 1999-11-30 | Pentech Pharmaceuticals, Inc. | Amelioration of apomorphine adverse effects |
| BR0005797A (pt) * | 2000-03-20 | 2001-10-16 | Abbott Lab | Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados |
| US20020169166A1 (en) | 2001-03-09 | 2002-11-14 | Cowart Marlon D. | Benzimidazoles that are useful in treating sexual dysfunction |
| US20030008878A1 (en) | 2001-03-09 | 2003-01-09 | Cowart Marlon D. | Benzimidazoles that are useful in treating sexual dysfunction |
| ITMI20011321A1 (it) * | 2001-06-22 | 2002-12-22 | Chiesi Farma Spa | Composizione farmaceutica in forma di microemulsione atta alla somministrazione per via transdermale di apomorfina utile nel trattamento del |
| US20040028613A1 (en) | 2001-06-25 | 2004-02-12 | Nastech Pharmaceutical Company Inc | Dopamine agonist formulations for enhanced central nervous system delivery |
| PE20030762A1 (es) | 2001-12-18 | 2003-09-05 | Schering Corp | Compuestos heterociclicos como antagonistas nk1 |
| US6939094B2 (en) | 2003-01-28 | 2005-09-06 | Macro Technologies Inc. | Autonomous power interface for modifying limited rotation speed of a machine |
| WO2004089988A2 (en) | 2003-04-03 | 2004-10-21 | Protein Design Labs, Inc | Inhibitors of integrin alpha5beta1 and their use for the control of tissue granulation |
| US20050090518A1 (en) * | 2003-10-24 | 2005-04-28 | Nastech Pharmaceutical Company Inc. | Method for treating parkinson's disease using apomorphine and apomorphine prodrugs |
| US20070197602A1 (en) * | 2004-02-09 | 2007-08-23 | Hashime Kanazawa | Combined pharmaceutical composition |
| EA200802348A1 (ru) | 2006-05-24 | 2009-08-28 | Байер Шеринг Фарма Акциенгезельшафт | ЧЕЛОВЕЧЕСКИЙ ВЫСОКОАФФИННЫЙ И ГУМАНИЗИРОВАННЫЙ АНТИ-α5β1 ИНТЕГРИН С ФУНКЦИЕЙ БЛОКИРУЮЩЕГО АНТИТЕЛА С ОСЛАБЛЕННОЙ ИММУНОГЕННОСТЬЮ |
| US20080171072A1 (en) * | 2006-08-11 | 2008-07-17 | Frank Burczynski | Ocular inserts containing apomorphine |
| US8741918B2 (en) * | 2007-06-21 | 2014-06-03 | Veroscience Llc | Parenteral formulations of dopamine agonists |
| EP2057982A1 (en) * | 2007-11-09 | 2009-05-13 | Archimedes Development Limited | Intranasal compositions |
| CN101712675B (zh) * | 2008-10-07 | 2013-07-03 | 江苏恒谊药业有限公司 | 苯并含氮杂环衍生物及其在治疗神经精神疾病药物的应用 |
| EP2545905A1 (en) * | 2011-07-11 | 2013-01-16 | Britannia Pharmaceuticals Limited | A new therapeutical composition containing apomorphine as active ingredient |
-
2011
- 2011-07-11 EP EP11290320A patent/EP2545905A1/en not_active Withdrawn
-
2012
- 2012-07-11 EP EP12735463.7A patent/EP2731589A1/en not_active Withdrawn
- 2012-07-11 CN CN201810378574.0A patent/CN108434094A/zh active Pending
- 2012-07-11 PH PH1/2014/500065A patent/PH12014500065A1/en unknown
- 2012-07-11 MY MYPI2014000016A patent/MY168212A/en unknown
- 2012-07-11 AU AU2012283381A patent/AU2012283381B2/en active Active
- 2012-07-11 CU CU20140005A patent/CU24159B1/es active IP Right Grant
- 2012-07-11 WO PCT/EP2012/002916 patent/WO2013007381A1/en not_active Ceased
- 2012-07-11 MX MX2014000454A patent/MX389600B/es unknown
- 2012-07-11 CN CN201280034745.9A patent/CN103826612B/zh active Active
- 2012-07-11 EA EA201400067A patent/EA025870B1/ru not_active IP Right Cessation
- 2012-07-11 BR BR112014000306-8A patent/BR112014000306B1/pt active IP Right Grant
- 2012-07-11 IN IN90DEN2014 patent/IN2014DN00090A/en unknown
- 2012-07-11 GE GEAP201213377A patent/GEP20196969B/en unknown
- 2012-07-11 KR KR1020147001302A patent/KR101990897B1/ko active Active
- 2012-07-11 JP JP2014519451A patent/JP6356064B2/ja active Active
- 2012-07-11 CA CA2841807A patent/CA2841807C/en active Active
- 2012-07-11 UA UAA201400117A patent/UA113962C2/uk unknown
- 2012-07-11 SG SG10201605491PA patent/SG10201605491PA/en unknown
- 2012-07-11 PE PE2014000051A patent/PE20141539A1/es active IP Right Grant
-
2013
- 2013-12-20 ZA ZA2013/09711A patent/ZA201309711B/en unknown
-
2014
- 2014-01-02 TN TNP2014000001A patent/TN2014000001A1/en unknown
- 2014-01-02 IL IL230308A patent/IL230308A/en active IP Right Grant
- 2014-01-07 CR CR20140005A patent/CR20140005A/es unknown
- 2014-01-09 DO DO2014000003A patent/DOP2014000003A/es unknown
- 2014-01-09 GT GT201400003A patent/GT201400003A/es unknown
- 2014-01-09 CL CL2014000050A patent/CL2014000050A1/es unknown
- 2014-01-09 NI NI201400003A patent/NI201400003A/es unknown
- 2014-01-10 MX MX2021010046A patent/MX2021010046A/es unknown
- 2014-01-10 US US14/152,000 patent/US11026938B2/en active Active
- 2014-02-03 MA MA36727A patent/MA35411B1/fr unknown
- 2014-02-04 CO CO14022989A patent/CO6870038A2/es unknown
- 2014-02-11 EC EC2014013200A patent/ECSP14013200A/es unknown
-
2016
- 2016-06-30 US US15/199,070 patent/US20160310480A1/en not_active Abandoned
- 2016-12-08 JP JP2016238705A patent/JP2017081947A/ja active Pending
-
2017
- 2017-12-13 US US15/840,585 patent/US20180098981A1/en not_active Abandoned
-
2021
- 2021-04-30 US US17/245,209 patent/US11766431B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014518285A5 (enExample) | ||
| KR100849537B1 (ko) | 코엔자임 큐텐의 나노에멀젼 조성물 | |
| JP6913458B2 (ja) | 抗菌水 | |
| JP5485879B2 (ja) | 異なる物性の薬物の一剤形化 | |
| RU2671208C2 (ru) | Композиции, содержащие 15-он эпк, и способы их применения | |
| RU2011145278A (ru) | Композиции клозапина с контролируемым высвобождением | |
| JP2014506914A5 (enExample) | ||
| JPWO2006019140A1 (ja) | ゼリー組成物 | |
| JPWO2005060935A1 (ja) | 薬物を含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる非経口投与用製剤 | |
| CN105287361B (zh) | 含有非甾体抗炎药微乳的皮肤外用制剂 | |
| RU2013144383A (ru) | Лекарственная форма и применение диэтилстильбестрола для лечения рака предстательной железы или молочной железы | |
| JP6903410B2 (ja) | 水中油型乳化組成物 | |
| JP2016514680A5 (enExample) | ||
| CN102740891A (zh) | 载体组合物 | |
| JPWO2009031318A1 (ja) | 鎮痛・抗炎症剤含有外用剤 | |
| JP2021185139A5 (enExample) | ||
| KR20110127687A (ko) | 진통·항염증제 함유 외용제 | |
| JP5054847B1 (ja) | 外用剤キット | |
| JP2013545802A5 (enExample) | ||
| CN109640958B (zh) | 包含选择性雌激素受体调节剂(serm)的阴道递送系统及其用途 | |
| TW200930381A (en) | Compositions and methods for the treatment of bladder cancer | |
| JP2008532967A5 (enExample) | ||
| WO2015195990A1 (en) | Liquid-filled immediate release soft gelatin capsules | |
| CN103859395B (zh) | 一种高吸收率的辅酶q10的自乳化释药体系及其制备方法及应用 | |
| JP6014252B2 (ja) | ネパデュタントを含有する小児用経口液体組成物 |